Genomic stocks are about to boom into a revolutionary era of biotech advances that could mean sales growth as high as 35,000% for one of these stocks. Gene editing and biotech stocks need to be a part of your portfolio if you want 10X returns over the next decade!

Follow these and all the stocks in our 2021 Bow Tie Nation portfolio on Stockcard. Use promo code bowtienation for a special discount beyond the free trial! https://mystockmarketbasics.com/stock...

Advances in artificial intelligence is enabling faster gene sequencing and testing. That’s leading to a boom in gene therapies and speeding up the approval process. There are currently just 10 approved gene therapies but more than 700 in trials. That could mean approved techniques jump 10-fold to over 170 therapies.

It’s going to open up a $400 billion addressable market in gene editing, therapies and multi-cancer screening and one of the biggest themes over the next decade. In fact, ARK Invest dedicates three sections to this in the ARK Invest Big Ideas Report. These breakthroughs in genomic companies could save lives, extend living and even cure some diseases.

In this video, I’ll show you the research into genomic stocks and how to pick the best biotech stocks to buy. Then I’ll reveal five gene editing stocks that need to be on every investor’s radar.

Don’t miss these other videos in our Ark Invest Big Ideas series for the stocks you need to own for the biggest trends of the decade!
5 Fintech Stocks in my Favorite Growth Theme    • Top 5 Fintech Growth Stock Picks from...  
5 AI Stocks Changing our Lives for the Better    • 5 Artificial Intelligence Stocks to B...  
Two Ways to Value Bitcoin and Why I’m Investing NOW!    • Bitcoin Value Analysis | How Much is ...  
5 Space Stocks to Buy BEFORE ARKX Launches    • 5 Space Stocks to Buy Before the ARKX...  
Top 7 Car Stocks for a Self-Driving Future    • Top 7 Car Stocks for a Self-Driving F...  
5 3D Printing Stocks I’m Watching    • Top 5 Stocks to Buy in the 3D Printin...  

Of course, the question you’re asking is why not just invest in the ARK Invest Gene Revolution ETF, ticker ARKG, instead of in these individual genomic stocks? I own the fund myself but it’s not a pure play on the gene editing and biotech revolution. There are a lot of related medical companies. In fact, the largest holding is in a health information company that has nothing to do with gene editing or therapies. If you want to invest in pure plays in this theme, you have to do it with these individual genomic stocks.

🤑 Get The Daily Bow-Tie - my FREE daily email newsletter sharing market updates, trends and the most important news! Market Updates for the Smart Investor! https://mystockmarketbasics.com/daily...

My Investing Recommendations 📈

📊 Download this Portfolio Tracker and Investing Spreadsheet! [Community Discount Code] https://mystockmarketbasics.com/sprea...

Check out the stock simulator and Get a FREE share of stock worth up to $1000 when you open a Webull investing account with a $100 deposit! 🤑 https://mystockmarketbasics.com/webull

Follow the 2021 Bow Tie Nation portfolio on Stockcard and get a special 10% discount with promo code: bowtienation https://mystockmarketbasics.com/stock...

Free Webinar – Discover how to create a personal investing plan and beat your goals in less than an hour! I’m revealing the Goals-Based Investing Strategy I developed working private wealth management in this free webinar. Reserve your spot now! https://mystockmarketbasics.com/free-...

₿ Use Coinbase, the largest and safest platform to buy cryptocurrencies and get bonus crypto while you learn! https://mystockmarketbasics.com/coinbase

Joseph Hogue, CFA spent nearly a decade as an investment analyst for institutional firms and banks. He now helps people understand their financial lives through debt payoff strategies, investing and ways to save more money. He has appeared on Bloomberg and on sites like CNBC and Morningstar. He holds the Chartered Financial Analyst (CFA) designation and is a veteran of the Marine Corps.
#stocks #stockstobuy #stockmarket